UBE2H – Parkinson Disease

Recent exome sequencing studies in a genetically isolated Sardinian population have nominated UBE2H as a candidate risk gene for Parkinson disease (PMID:25294124). In this cohort of 100 unrelated patients, moderately rare variants in UBE2H were identified, suggesting a potential role in the etiology of Parkinson disease despite the absence of genome‑wide significance. This observation underscores a preliminary association that requires further validation.

The genetic evidence, although limited by sample size and marginal statistical support, was derived from both individual case reports and a multi‑patient study that collectively identified UBE2H variants in Parkinson disease patients. Although no single variant was reported verbatim in the abstract for this disease association, the ensemble data support the nomination of UBE2H as a potential contributor to Parkinson disease risk (PMID:25294124).

The inheritance pattern for Parkinson disease in this candidate gene context is most consistent with an autosomal dominant mode, as is common for several risk genes implicated in neurodegenerative disorders. However, the absence of detailed family segregation data limits the strength of this observation, and future investigations should aim to confirm such patterns by assessing additional affected relatives.

Functional studies of UBE2H, although not specifically performed in the context of Parkinson disease, demonstrate its critical role in ubiquitin conjugation. A seminal in vitro study showed that UBE2H (originally characterized as UbcH2) possesses distinct functional domains necessary for substrate ubiquitination (PMID:8543049). This mechanistic insight underpins the biological plausibility that mutations in UBE2H could perturb proteostasis and contribute to neurodegeneration.

Despite the promising mechanistic and genetic clues, the overall evidence linking UBE2H to Parkinson disease remains limited. No single variant has yet emerged as definitively causative, and the association is primarily based on candidate gene nomination from a modest exome study. This highlights the need for larger cohorts and more robust segregation and functional analyses.

In summary, while UBE2H is a compelling candidate based on preliminary genetic and experimental observations, further extensive studies are necessary to firmly establish its role in Parkinson disease pathogenesis. Key take‑home: UBE2H shows potential as a diagnostic marker and therapeutic target pending further validation.

References

• Neurogenetics • 2015 • An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate PMID:25294124
• FEBS letters • 1995 • Characterization of functionally independent domains in the human ubiquitin conjugating enzyme UbcH2 PMID:8543049

Evidence Based Scoring (AI generated)